Human Immunoglobulin G Cannot Inhibit Fibrinogen Binding by the Genetically Diverse A Domain of <named-content content-type="genus-species">Staphylococcus aureus</named-content> Fibronectin-Binding Protein A

ABSTRACT The fibronectin-binding protein A (FnBPA) is a cell surface-associated protein of Staphylococcus aureus which mediates adherence to the host extracellular matrix and is important for bacterial virulence. Previously, substantial sequence diversity was found among strains in the fibrinogen-bi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: P. Martijn den Reijer, Mehri Tavakol, Nicole Lemmens-den Toom, Dikra Allouch, Sheila Thomas, Vannakambadi K. Ganesh, Ya-Ping Ko, Henri A. Verbrugh, Willem J. B. van Wamel
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2018
Materias:
Acceso en línea:https://doaj.org/article/da1ec3d8e8bb47a68f575bab5078855f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:da1ec3d8e8bb47a68f575bab5078855f
record_format dspace
spelling oai:doaj.org-article:da1ec3d8e8bb47a68f575bab5078855f2021-11-15T15:22:14ZHuman Immunoglobulin G Cannot Inhibit Fibrinogen Binding by the Genetically Diverse A Domain of <named-content content-type="genus-species">Staphylococcus aureus</named-content> Fibronectin-Binding Protein A10.1128/mSphere.00590-172379-5042https://doaj.org/article/da1ec3d8e8bb47a68f575bab5078855f2018-04-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mSphere.00590-17https://doaj.org/toc/2379-5042ABSTRACT The fibronectin-binding protein A (FnBPA) is a cell surface-associated protein of Staphylococcus aureus which mediates adherence to the host extracellular matrix and is important for bacterial virulence. Previously, substantial sequence diversity was found among strains in the fibrinogen-binding A domain of this protein, and 7 different isotypes were described. The effect of this sequence diversity on the human antibody response, in terms of both antibody production and antibody function, remains unclear. In this study, we identify five different FnBPA A domain isotypes based on the sequence results of 22 clinical S. aureus isolates, obtained from the same number of patients suffering from bacteremia. Using a bead-based Luminex technique, we measure the patients’ total immunoglobulin G (IgG) against the 7 FnBPA isotypes at the onset and during the time course of bacteremia (median of 10 serum samples per patient over a median of 35 days). A significant increase in IgG against the FnBPA A domain, including the isotype carried by the infecting strain, is observed in only three out of 22 patients (14%) after the onset of bacteremia. Using a Luminex-based FnBPA–fibrinogen-binding assay, we find that preincubation of recombinant FnBPA isotypes with IgG from diverse patients does not interfere with binding to fibrinogen. This observation is confirmed using an alternative Luminex-based assay and enzyme-linked immunosorbent assay (ELISA). IMPORTANCE Despite the many in vitro and murine in vivo studies involving FnBPA, the actual presence of this virulence factor during human infection is less well established. Furthermore, it is currently unknown to what extent sequence variation in such a virulence factor affects the human antibody response and the ability of antibodies to interfere with FnBPA function. This study sheds new light on these issues. First, the uniform presence of a patient’s IgG against FnBPA indicates the presence and importance of this virulence factor during S. aureus pathogenesis. Second, the absence of an increase in antibody production in most patients following bacteremia indicates the complexity of S. aureus-host interactions, possibly involving immune evasion or lack of expression of FnBPA during invasive infection. Finally, we provide new insights into the inability of human antibodies to interfere with FnBPA-fibrinogen binding. These observations should be taken into account during the development of novel vaccination approaches.P. Martijn den ReijerMehri TavakolNicole Lemmens-den ToomDikra AllouchSheila ThomasVannakambadi K. GaneshYa-Ping KoHenri A. VerbrughWillem J. B. van WamelAmerican Society for MicrobiologyarticleStaphylococcus aureusantibody functionantibody repertoirebacteremiafibrinogenfibronectin-binding protein AMicrobiologyQR1-502ENmSphere, Vol 3, Iss 2 (2018)
institution DOAJ
collection DOAJ
language EN
topic Staphylococcus aureus
antibody function
antibody repertoire
bacteremia
fibrinogen
fibronectin-binding protein A
Microbiology
QR1-502
spellingShingle Staphylococcus aureus
antibody function
antibody repertoire
bacteremia
fibrinogen
fibronectin-binding protein A
Microbiology
QR1-502
P. Martijn den Reijer
Mehri Tavakol
Nicole Lemmens-den Toom
Dikra Allouch
Sheila Thomas
Vannakambadi K. Ganesh
Ya-Ping Ko
Henri A. Verbrugh
Willem J. B. van Wamel
Human Immunoglobulin G Cannot Inhibit Fibrinogen Binding by the Genetically Diverse A Domain of <named-content content-type="genus-species">Staphylococcus aureus</named-content> Fibronectin-Binding Protein A
description ABSTRACT The fibronectin-binding protein A (FnBPA) is a cell surface-associated protein of Staphylococcus aureus which mediates adherence to the host extracellular matrix and is important for bacterial virulence. Previously, substantial sequence diversity was found among strains in the fibrinogen-binding A domain of this protein, and 7 different isotypes were described. The effect of this sequence diversity on the human antibody response, in terms of both antibody production and antibody function, remains unclear. In this study, we identify five different FnBPA A domain isotypes based on the sequence results of 22 clinical S. aureus isolates, obtained from the same number of patients suffering from bacteremia. Using a bead-based Luminex technique, we measure the patients’ total immunoglobulin G (IgG) against the 7 FnBPA isotypes at the onset and during the time course of bacteremia (median of 10 serum samples per patient over a median of 35 days). A significant increase in IgG against the FnBPA A domain, including the isotype carried by the infecting strain, is observed in only three out of 22 patients (14%) after the onset of bacteremia. Using a Luminex-based FnBPA–fibrinogen-binding assay, we find that preincubation of recombinant FnBPA isotypes with IgG from diverse patients does not interfere with binding to fibrinogen. This observation is confirmed using an alternative Luminex-based assay and enzyme-linked immunosorbent assay (ELISA). IMPORTANCE Despite the many in vitro and murine in vivo studies involving FnBPA, the actual presence of this virulence factor during human infection is less well established. Furthermore, it is currently unknown to what extent sequence variation in such a virulence factor affects the human antibody response and the ability of antibodies to interfere with FnBPA function. This study sheds new light on these issues. First, the uniform presence of a patient’s IgG against FnBPA indicates the presence and importance of this virulence factor during S. aureus pathogenesis. Second, the absence of an increase in antibody production in most patients following bacteremia indicates the complexity of S. aureus-host interactions, possibly involving immune evasion or lack of expression of FnBPA during invasive infection. Finally, we provide new insights into the inability of human antibodies to interfere with FnBPA-fibrinogen binding. These observations should be taken into account during the development of novel vaccination approaches.
format article
author P. Martijn den Reijer
Mehri Tavakol
Nicole Lemmens-den Toom
Dikra Allouch
Sheila Thomas
Vannakambadi K. Ganesh
Ya-Ping Ko
Henri A. Verbrugh
Willem J. B. van Wamel
author_facet P. Martijn den Reijer
Mehri Tavakol
Nicole Lemmens-den Toom
Dikra Allouch
Sheila Thomas
Vannakambadi K. Ganesh
Ya-Ping Ko
Henri A. Verbrugh
Willem J. B. van Wamel
author_sort P. Martijn den Reijer
title Human Immunoglobulin G Cannot Inhibit Fibrinogen Binding by the Genetically Diverse A Domain of <named-content content-type="genus-species">Staphylococcus aureus</named-content> Fibronectin-Binding Protein A
title_short Human Immunoglobulin G Cannot Inhibit Fibrinogen Binding by the Genetically Diverse A Domain of <named-content content-type="genus-species">Staphylococcus aureus</named-content> Fibronectin-Binding Protein A
title_full Human Immunoglobulin G Cannot Inhibit Fibrinogen Binding by the Genetically Diverse A Domain of <named-content content-type="genus-species">Staphylococcus aureus</named-content> Fibronectin-Binding Protein A
title_fullStr Human Immunoglobulin G Cannot Inhibit Fibrinogen Binding by the Genetically Diverse A Domain of <named-content content-type="genus-species">Staphylococcus aureus</named-content> Fibronectin-Binding Protein A
title_full_unstemmed Human Immunoglobulin G Cannot Inhibit Fibrinogen Binding by the Genetically Diverse A Domain of <named-content content-type="genus-species">Staphylococcus aureus</named-content> Fibronectin-Binding Protein A
title_sort human immunoglobulin g cannot inhibit fibrinogen binding by the genetically diverse a domain of <named-content content-type="genus-species">staphylococcus aureus</named-content> fibronectin-binding protein a
publisher American Society for Microbiology
publishDate 2018
url https://doaj.org/article/da1ec3d8e8bb47a68f575bab5078855f
work_keys_str_mv AT pmartijndenreijer humanimmunoglobulingcannotinhibitfibrinogenbindingbythegeneticallydiverseadomainofnamedcontentcontenttypegenusspeciesstaphylococcusaureusnamedcontentfibronectinbindingproteina
AT mehritavakol humanimmunoglobulingcannotinhibitfibrinogenbindingbythegeneticallydiverseadomainofnamedcontentcontenttypegenusspeciesstaphylococcusaureusnamedcontentfibronectinbindingproteina
AT nicolelemmensdentoom humanimmunoglobulingcannotinhibitfibrinogenbindingbythegeneticallydiverseadomainofnamedcontentcontenttypegenusspeciesstaphylococcusaureusnamedcontentfibronectinbindingproteina
AT dikraallouch humanimmunoglobulingcannotinhibitfibrinogenbindingbythegeneticallydiverseadomainofnamedcontentcontenttypegenusspeciesstaphylococcusaureusnamedcontentfibronectinbindingproteina
AT sheilathomas humanimmunoglobulingcannotinhibitfibrinogenbindingbythegeneticallydiverseadomainofnamedcontentcontenttypegenusspeciesstaphylococcusaureusnamedcontentfibronectinbindingproteina
AT vannakambadikganesh humanimmunoglobulingcannotinhibitfibrinogenbindingbythegeneticallydiverseadomainofnamedcontentcontenttypegenusspeciesstaphylococcusaureusnamedcontentfibronectinbindingproteina
AT yapingko humanimmunoglobulingcannotinhibitfibrinogenbindingbythegeneticallydiverseadomainofnamedcontentcontenttypegenusspeciesstaphylococcusaureusnamedcontentfibronectinbindingproteina
AT henriaverbrugh humanimmunoglobulingcannotinhibitfibrinogenbindingbythegeneticallydiverseadomainofnamedcontentcontenttypegenusspeciesstaphylococcusaureusnamedcontentfibronectinbindingproteina
AT willemjbvanwamel humanimmunoglobulingcannotinhibitfibrinogenbindingbythegeneticallydiverseadomainofnamedcontentcontenttypegenusspeciesstaphylococcusaureusnamedcontentfibronectinbindingproteina
_version_ 1718428038354436096